Broncus Holding Corporation

Equities

2216

KYG1609T1022

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. 04:09:09 2024-04-25 am EDT 5-day change 1st Jan Change
0.51 HKD -5.56% Intraday chart for Broncus Holding Corporation -5.56% -35.44%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Broncus Chairman Resigns; Successor Named MT
Broncus Holding Corporation Announces Changes to Its Board CI
Broncus Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Broncus Holding Corporation Announces Resignation of Zhenjun Zi as Non-Executive Director CI
Broncus Holding Corporation Announces Passing Away of Joseph Wan Yee Lau, an Independent Non-Executive Director and Member of the Audit Committee and Nomination Committee CI
Broncus Arm Terminates License Agreement With NoahTron Intelligence MT
Broncus Unit to Purchase Medical Device Maker MT
Broncus Acquires Fibernova for $2.7 Million MT
Broncus Holding Corporation entered into share purchase agreement to acquire Fibernova Holding Corporation from from Zhao and others for $2.7 million. CI
Broncus Holding Corporation Announces Chief Executive Officer Changes, Effective on September 1, 2023 CI
Broncus Holding Corporation Announces Re-Designation of Guowei Zhan from an Executive Director to Non-Executive Director, Effective September 1, 2023 CI
Broncus Holding Corporation Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Broncus Holding Corporation Completes the First Case of Registered Clinical Trials of Its Targeted Lung Denervation Radiofrequency Ablation System CI
Broncus Completes First Case of Clinical Trials for COPD Treatment MT
Broncus Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Broncus Flags Nearly $12 Million Exposure to Silicon Valley Bank MT
Chinese shares jump on recovery optimism, Fed pause bets RE
Over a dozen Chinese-based firms say they have minimal exposure to SVB RE
Six Hong Kong-listed firms say their deposits at SVB are immaterial RE
TechStar Acquisition Launches Hong Kong IPO MT
Broncus Holding Corporation Announces Zhejiang Medical Products Administration Approves Disposable Nebulizing Micro-Catheter for Endoscope for Marketing in China CI
China Approves Market Launch of Broncus Nebulizing Micro-catheter MT
Certain Ordinary Shares of Broncus Holding Corporation are subject to a Lock-Up Agreement Ending on 25-SEP-2022. CI
Broncus Holding Corporation(SEHK:2216) dropped from S&P Global BMI Index CI
Healium Medical Enters into Strategic Cooperation Agreement with Broncus Holding Corporation CI
Chart Broncus Holding Corporation
More charts
Broncus Holding Corp is a China-based investment holding company providing innovative solutions for lung diseases. The Company's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0651 USD
Average target price
0.137 USD
Spread / Average Target
+110.29%
Consensus
  1. Stock Market
  2. Equities
  3. 2216 Stock
  4. News Broncus Holding Corporation
  5. Broncus to Invest $3 Million in Member of Consortium for New Frontier Health's Go-Private Deal